“Overview of the Safety Profile From Efgartigimod Clinical Trials in Participants With Diverse IgG-Mediated Autoimmune Diseases”. SKIN The Journal of Cutaneous Medicine 8, no. 1 (January 16, 2024): s344. Accessed April 30, 2026. https://skin.dermsquared.com/skin/article/view/2350.